ID   PAR6B_HUMAN             Reviewed;         372 AA.
AC   Q9BYG5; A2A2A7; Q9Y510;
DT   16-MAY-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   18-JUN-2025, entry version 193.
DE   RecName: Full=Partitioning defective 6 homolog beta;
DE            Short=PAR-6 beta;
DE            Short=PAR-6B;
GN   Name=PARD6B; Synonyms=PAR6B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INTERACTION WITH PRKCI; PRKCZ;
RP   RAC1 AND CDC42.
RC   TISSUE=Neuroblastoma;
RX   PubMed=11260256; DOI=10.1046/j.1365-2443.2001.00404.x;
RA   Noda Y., Takeya R., Ohno S., Naito S., Ito T., Sumimoto H.;
RT   "Human homologues of the Caenorhabditis elegans cell polarity protein PAR6
RT   as an adaptor that links the small GTPases Rac and Cdc42 to atypical
RT   protein kinase C.";
RL   Genes Cells 6:107-119(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Noda Y., Kohjima M., Izaki T., Sumimoto H.;
RT   "Splicing variants of the cell polarity protein PAR-6.";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INTERACTION WITH PARD3B AND PARD3.
RX   PubMed=12234671; DOI=10.1016/s0378-1119(02)00681-9;
RA   Gao L., Macara I.G., Joberty G.;
RT   "Multiple splice variants of Par3 and of a novel related gene, Par3L,
RT   produce proteins with different binding properties.";
RL   Gene 294:99-107(2002).
RN   [6]
RP   INTERACTION WITH LLGL1 AND PRKCI.
RX   PubMed=12725730; DOI=10.1016/s0960-9822(03)00244-6;
RA   Yamanaka T., Horikoshi Y., Sugiyama Y., Ishiyama C., Suzuki A., Hirose T.,
RA   Iwamatsu A., Shinohara A., Ohno S.;
RT   "Mammalian Lgl forms a protein complex with PAR-6 and aPKC independently of
RT   PAR-3 to regulate epithelial cell polarity.";
RL   Curr. Biol. 13:734-743(2003).
RN   [7]
RP   INTERACTION WITH ECT2.
RX   PubMed=15254234; DOI=10.1128/mcb.24.15.6665-6675.2004;
RA   Liu X.F., Ishida H., Raziuddin R., Miki T.;
RT   "Nucleotide exchange factor ECT2 interacts with the polarity protein
RT   complex Par6/Par3/protein kinase Czeta (PKCzeta) and regulates PKCzeta
RT   activity.";
RL   Mol. Cell. Biol. 24:6665-6675(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Adapter protein involved in asymmetrical cell division and
CC       cell polarization processes. Probably involved in formation of
CC       epithelial tight junctions. Association with PARD3 may prevent the
CC       interaction of PARD3 with F11R/JAM1, thereby preventing tight junction
CC       assembly. The PARD6-PARD3 complex links GTP-bound Rho small GTPases to
CC       atypical protein kinase C proteins.
CC   -!- SUBUNIT: Interacts with PARD3. Interacts with GTP-bound forms of CDC42
CC       and RAC1. Interacts with GTP-bound RHOQ/TC10. Interacts with PALS1 (By
CC       similarity). Interacts with the N-terminal part of PRKCI and PRKCZ.
CC       Part of a complex with PARD3, CDC42 or RAC1 and PRKCI or PRKCZ. Part of
CC       a complex with LLGL1 and PRKCI. Interacts with PARD3B. Interacts with
CC       ECT2. {ECO:0000250, ECO:0000269|PubMed:11260256,
CC       ECO:0000269|PubMed:12234671, ECO:0000269|PubMed:12725730,
CC       ECO:0000269|PubMed:15254234}.
CC   -!- INTERACTION:
CC       Q9BYG5; Q8N9N5-2: BANP; NbExp=3; IntAct=EBI-295391, EBI-11524452;
CC       Q9BYG5; P60953: CDC42; NbExp=18; IntAct=EBI-295391, EBI-81752;
CC       Q9BYG5; Q9BXL8: CDCA4; NbExp=3; IntAct=EBI-295391, EBI-1773949;
CC       Q9BYG5; Q8TAP6: CEP76; NbExp=6; IntAct=EBI-295391, EBI-742887;
CC       Q9BYG5; Q53SE7: FLJ13057; NbExp=3; IntAct=EBI-295391, EBI-10172181;
CC       Q9BYG5; Q96NE9-2: FRMD6; NbExp=3; IntAct=EBI-295391, EBI-13213391;
CC       Q9BYG5; Q96IK5: GMCL1; NbExp=3; IntAct=EBI-295391, EBI-2548508;
CC       Q9BYG5; Q08379: GOLGA2; NbExp=3; IntAct=EBI-295391, EBI-618309;
CC       Q9BYG5; O75031: HSF2BP; NbExp=3; IntAct=EBI-295391, EBI-7116203;
CC       Q9BYG5; Q96A72: MAGOHB; NbExp=3; IntAct=EBI-295391, EBI-746778;
CC       Q9BYG5; Q8TEW0: PARD3; NbExp=7; IntAct=EBI-295391, EBI-81968;
CC       Q9BYG5; Q8ND90: PNMA1; NbExp=2; IntAct=EBI-295391, EBI-302345;
CC       Q9BYG5; P41743: PRKCI; NbExp=25; IntAct=EBI-295391, EBI-286199;
CC       Q9BYG5; Q05513: PRKCZ; NbExp=18; IntAct=EBI-295391, EBI-295351;
CC       Q9BYG5; P63000: RAC1; NbExp=3; IntAct=EBI-295391, EBI-413628;
CC       Q9BYG5; P60763: RAC3; NbExp=3; IntAct=EBI-295391, EBI-767084;
CC       Q9BYG5; Q86WH2: RASSF3; NbExp=3; IntAct=EBI-295391, EBI-2845202;
CC       Q9BYG5; Q9H4E5: RHOJ; NbExp=7; IntAct=EBI-295391, EBI-6285694;
CC       Q9BYG5; P17081: RHOQ; NbExp=3; IntAct=EBI-295391, EBI-689202;
CC       Q9BYG5; Q96RU7: TRIB3; NbExp=3; IntAct=EBI-295391, EBI-492476;
CC       Q9BYG5; Q9UPQ4-2: TRIM35; NbExp=3; IntAct=EBI-295391, EBI-17716262;
CC       Q9BYG5; Q04917: YWHAH; NbExp=3; IntAct=EBI-295391, EBI-306940;
CC       Q9BYG5; Q8NAM6: ZSCAN4; NbExp=3; IntAct=EBI-295391, EBI-7252920;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cell membrane {ECO:0000250}. Cell
CC       junction, tight junction {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BYG5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BYG5-2; Sequence=VSP_053311, VSP_053312;
CC   -!- TISSUE SPECIFICITY: Expressed in pancreas and in both adult and fetal
CC       kidney. Weakly expressed in placenta and lung. Not expressed in other
CC       tissues.
CC   -!- DOMAIN: The pseudo-CRIB domain together with the PDZ domain is required
CC       for the interaction with Rho small GTPases.
CC   -!- DOMAIN: The PDZ domain mediates interaction with PALS1. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the PAR6 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB044555; BAB40756.1; -; mRNA.
DR   EMBL; AB178534; BAF92013.1; -; mRNA.
DR   EMBL; AL031680; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC060847; AAH60847.1; -; mRNA.
DR   CCDS; CCDS33485.1; -. [Q9BYG5-1]
DR   RefSeq; NP_115910.1; NM_032521.3. [Q9BYG5-1]
DR   AlphaFoldDB; Q9BYG5; -.
DR   SMR; Q9BYG5; -.
DR   BioGRID; 124145; 143.
DR   ComplexPortal; CPX-6193; PAR cell polarity complex, PARD6B-PRKCI variant.
DR   ComplexPortal; CPX-6196; PAR cell polarity complex, PARD6B-PRKCZ variant.
DR   CORUM; Q9BYG5; -.
DR   FunCoup; Q9BYG5; 2221.
DR   IntAct; Q9BYG5; 91.
DR   MINT; Q9BYG5; -.
DR   STRING; 9606.ENSP00000360672; -.
DR   iPTMnet; Q9BYG5; -.
DR   PhosphoSitePlus; Q9BYG5; -.
DR   BioMuta; PARD6B; -.
DR   DMDM; 30913176; -.
DR   jPOST; Q9BYG5; -.
DR   MassIVE; Q9BYG5; -.
DR   PaxDb; 9606-ENSP00000360672; -.
DR   PeptideAtlas; Q9BYG5; -.
DR   ProteomicsDB; 187; -.
DR   ProteomicsDB; 79639; -. [Q9BYG5-1]
DR   Pumba; Q9BYG5; -.
DR   Antibodypedia; 2853; 164 antibodies from 30 providers.
DR   DNASU; 84612; -.
DR   Ensembl; ENST00000371610.7; ENSP00000360672.2; ENSG00000124171.9. [Q9BYG5-1]
DR   Ensembl; ENST00000396039.1; ENSP00000379354.1; ENSG00000124171.9. [Q9BYG5-2]
DR   GeneID; 84612; -.
DR   KEGG; hsa:84612; -.
DR   MANE-Select; ENST00000371610.7; ENSP00000360672.2; NM_032521.3; NP_115910.1.
DR   UCSC; uc002xvo.3; human. [Q9BYG5-1]
DR   AGR; HGNC:16245; -.
DR   CTD; 84612; -.
DR   DisGeNET; 84612; -.
DR   GeneCards; PARD6B; -.
DR   HGNC; HGNC:16245; PARD6B.
DR   HPA; ENSG00000124171; Tissue enhanced (kidney).
DR   MIM; 608975; gene.
DR   OpenTargets; ENSG00000124171; -.
DR   VEuPathDB; HostDB:ENSG00000124171; -.
DR   eggNOG; KOG3606; Eukaryota.
DR   GeneTree; ENSGT00950000183211; -.
DR   HOGENOM; CLU_040653_2_0_1; -.
DR   InParanoid; Q9BYG5; -.
DR   OMA; PGYPQQI; -.
DR   OrthoDB; 5868434at2759; -.
DR   PAN-GO; Q9BYG5; 7 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9BYG5; -.
DR   PathwayCommons; Q9BYG5; -.
DR   Reactome; R-HSA-420029; Tight junction interactions.
DR   Reactome; R-HSA-9013424; RHOV GTPase cycle.
DR   SignaLink; Q9BYG5; -.
DR   BioGRID-ORCS; 84612; 99 hits in 1157 CRISPR screens.
DR   ChiTaRS; PARD6B; human.
DR   GeneWiki; PARD6B; -.
DR   GenomeRNAi; 84612; -.
DR   Pharos; Q9BYG5; Tbio.
DR   PRO; PR:Q9BYG5; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; Q9BYG5; protein.
DR   Bgee; ENSG00000124171; Expressed in germinal epithelium of ovary and 144 other cell types or tissues.
DR   GO; GO:0016324; C:apical plasma membrane; IBA:GO_Central.
DR   GO; GO:0005923; C:bicellular tight junction; IDA:UniProtKB.
DR   GO; GO:0005938; C:cell cortex; IBA:GO_Central.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0120157; C:PAR polarity complex; ISS:ComplexPortal.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0070160; C:tight junction; NAS:ComplexPortal.
DR   GO; GO:0007409; P:axonogenesis; TAS:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0007043; P:cell-cell junction assembly; TAS:UniProtKB.
DR   GO; GO:0007098; P:centrosome cycle; IBA:GO_Central.
DR   GO; GO:0007163; P:establishment or maintenance of cell polarity; IBA:GO_Central.
DR   GO; GO:0045197; P:establishment or maintenance of epithelial cell apical/basal polarity; ISS:ComplexPortal.
DR   GO; GO:0065003; P:protein-containing complex assembly; IDA:UniProtKB.
DR   GO; GO:0030334; P:regulation of cell migration; TAS:UniProtKB.
DR   GO; GO:0060341; P:regulation of cellular localization; IBA:GO_Central.
DR   CDD; cd06403; PB1_Par6; 1.
DR   CDD; cd06718; PDZ_Par6-like; 1.
DR   FunFam; 3.10.20.90:FF:000031; Partitioning defective 6 homolog alpha; 1.
DR   FunFam; 2.30.42.10:FF:000030; Partitioning defective 6 homolog beta; 1.
DR   Gene3D; 2.30.42.10; -; 1.
DR   Gene3D; 3.10.20.90; Phosphatidylinositol 3-kinase Catalytic Subunit, Chain A, domain 1; 1.
DR   InterPro; IPR051741; PAR6_homolog.
DR   InterPro; IPR053793; PB1-like.
DR   InterPro; IPR000270; PB1_dom.
DR   InterPro; IPR034868; PB1_Par6.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   PANTHER; PTHR14102; PAR-6-RELATED; 1.
DR   PANTHER; PTHR14102:SF4; PARTITIONING DEFECTIVE 6 HOMOLOG BETA; 1.
DR   Pfam; PF00564; PB1; 1.
DR   Pfam; PF00595; PDZ; 1.
DR   SMART; SM00666; PB1; 1.
DR   SMART; SM00228; PDZ; 1.
DR   SUPFAM; SSF54277; CAD & PB1 domains; 1.
DR   SUPFAM; SSF50156; PDZ domain-like; 1.
DR   PROSITE; PS51745; PB1; 1.
DR   PROSITE; PS50106; PDZ; 1.
DR   neXtProt; NX_Q9BYG5; -.
DR   PharmGKB; PA32938; -.
DR   TreeFam; TF312899; -.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell cycle; Cell division; Cell junction;
KW   Cell membrane; Cytoplasm; Membrane; Phosphoprotein;
KW   Proteomics identification; Reference proteome; Tight junction.
FT   CHAIN           1..372
FT                   /note="Partitioning defective 6 homolog beta"
FT                   /id="PRO_0000112516"
FT   DOMAIN          16..96
FT                   /note="PB1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01081"
FT   DOMAIN          133..150
FT                   /note="Pseudo-CRIB"
FT   DOMAIN          157..250
FT                   /note="PDZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   REGION          126..253
FT                   /note="Interaction with PARD3 and CDC42"
FT                   /evidence="ECO:0000250"
FT   REGION          253..292
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        253..272
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         11
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         97..113
FT                   /note="EEADYSAFGTDTLIKKK -> GCVLEHSKNNVRMPCLK (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_053311"
FT   VAR_SEQ         114..370
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_053312"
SQ   SEQUENCE   372 AA;  41182 MW;  79B5392D72B15BDC CRC64;
     MNRSHRHGAG SGCLGTMEVK SKFGAEFRRF SLERSKPGKF EEFYGLLQHV HKIPNVDVLV
     GYADIHGDLL PINNDDNYHK AVSTANPLLR IFIQKKEEAD YSAFGTDTLI KKKNVLTNVL
     RPDNHRKKPH IVISMPQDFR PVSSIIDVDI LPETHRRVRL YKYGTEKPLG FYIRDGSSVR
     VTPHGLEKVP GIFISRLVPG GLAQSTGLLA VNDEVLEVNG IEVSGKSLDQ VTDMMIANSR
     NLIITVRPAN QRNNVVRNSR TSGSSGQSTD NSLLGYPQQI EPSFEPEDED SEEDDIIIED
     NGVPQQIPKA VPNTESLESL TQIELSFESG QNGFIPSNEV SLAAIASSSN TEFETHAPDQ
     KLLEEDGTII TL
//
